Association of H-FABP with cardiovascular events: A systematic review.

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Ambili Parekumbel Venu, Rajamanickam Rajkumar, Divakaran Dinesh Roy, Sreelal Thekkumkara Prabhakaran, Kanagasabapathy Shankar, Vidhyadharan Jayapal, Sureka Varalakshmi, Sreeja Sreenivasan
{"title":"Association of H-FABP with cardiovascular events: A systematic review.","authors":"Ambili Parekumbel Venu, Rajamanickam Rajkumar, Divakaran Dinesh Roy, Sreelal Thekkumkara Prabhakaran, Kanagasabapathy Shankar, Vidhyadharan Jayapal, Sureka Varalakshmi, Sreeja Sreenivasan","doi":"10.34172/jcvtr.33039","DOIUrl":null,"url":null,"abstract":"<p><p>The research aimed to evaluate the association between heart-type fatty acid binding protein (H-FABP) and cardiovascular events. We systematically reviewed research that has been conducted to assess this relationship, aiming to determine how useful H-FABP could be as a biomarker for cardiovascular diseases, especially in the initial phases of acute myocardial infarction (AMI) and acute coronary syndrome (ACS). Our goal was to validate its diagnostic accuracy and clinical relevance. We systematically searched through PubMed, Web of Science, and Google Scholar databases to find pertinent publications related to cardiovascular diseases and H-FABP, using various permutations, abbreviations, and language variations of MeSH keywords. The final analysis included 12 studies in total. The final study comprised twelve studies, and it was concluded that H-FABP demonstrated high sensitivity (64.3-91.5) and specificity (73-100) for diagnosing Acute Myocardial Infarction (AMI) and Acute Coronary Syndrome (ACS), especially within the first hours of symptom onset. H-FABP demonstrates potential in enhancing the overall diagnostic accuracy during the initial hours following the manifestation of symptoms. However, the existing data do not provide sufficient evidence to recommend the regular utilization of H-FABP as a preliminary risk assessment approach in individuals who present with suspected cardiac events. Additional investigations, with well-defined prospective cohorts, are needed to validate the results observed.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"16 2","pages":"77-87"},"PeriodicalIF":1.2000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380742/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular and Thoracic Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jcvtr.33039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

The research aimed to evaluate the association between heart-type fatty acid binding protein (H-FABP) and cardiovascular events. We systematically reviewed research that has been conducted to assess this relationship, aiming to determine how useful H-FABP could be as a biomarker for cardiovascular diseases, especially in the initial phases of acute myocardial infarction (AMI) and acute coronary syndrome (ACS). Our goal was to validate its diagnostic accuracy and clinical relevance. We systematically searched through PubMed, Web of Science, and Google Scholar databases to find pertinent publications related to cardiovascular diseases and H-FABP, using various permutations, abbreviations, and language variations of MeSH keywords. The final analysis included 12 studies in total. The final study comprised twelve studies, and it was concluded that H-FABP demonstrated high sensitivity (64.3-91.5) and specificity (73-100) for diagnosing Acute Myocardial Infarction (AMI) and Acute Coronary Syndrome (ACS), especially within the first hours of symptom onset. H-FABP demonstrates potential in enhancing the overall diagnostic accuracy during the initial hours following the manifestation of symptoms. However, the existing data do not provide sufficient evidence to recommend the regular utilization of H-FABP as a preliminary risk assessment approach in individuals who present with suspected cardiac events. Additional investigations, with well-defined prospective cohorts, are needed to validate the results observed.

H-FABP 与心血管事件的关系:系统回顾
这项研究旨在评估心脏型脂肪酸结合蛋白(H-FABP)与心血管事件之间的关系。我们系统地回顾了为评估这种关系而进行的研究,旨在确定 H-FABP 作为心血管疾病生物标志物的作用,尤其是在急性心肌梗塞(AMI)和急性冠状动脉综合征(ACS)的初期阶段。我们的目标是验证其诊断准确性和临床相关性。我们系统地搜索了 PubMed、Web of Science 和 Google Scholar 数据库,使用 MeSH 关键字的各种排列、缩写和语言变化来查找与心血管疾病和 H-FABP 相关的出版物。最终分析共包括 12 项研究。最终的研究包括 12 项研究,结论是 H-FABP 对诊断急性心肌梗塞(AMI)和急性冠状动脉综合征(ACS)具有较高的灵敏度(64.3-91.5)和特异性(73-100),尤其是在症状出现的最初几小时内。H-FABP 有助于提高症状出现后最初几小时内的整体诊断准确性。然而,现有数据并没有提供足够的证据来建议将 H-FABP 作为一种初步风险评估方法定期用于疑似心脏事件患者。要验证所观察到的结果,还需要对定义明确的前瞻性队列进行更多的调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cardiovascular and Thoracic Research
Journal of Cardiovascular and Thoracic Research CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.00
自引率
0.00%
发文量
22
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信